Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and one of the world's foremost educational forum specializing in interventional cardiovascular medicine, is marking its 34th year in 2022, from September 16-19 in Boston, returning to its pre-pandemic format.
Gallery | TCT | By Melinda Taschetta-Millane and Christine Book
Photo Gallery Highlighting TCT 2022

The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics ( ...

Home October 03, 2022
Home
News | ECG
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)

September 29, 2022 —  HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...

Home September 29, 2022
Home
Higher blood levels of collagen-derived molecule predict worse outcomes
News | Heart Failure
Penn Study Identifies New Prognostic Biomarker for Heart Failure

September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in ...

Home September 29, 2022
Home
Yeonsik Now, UMass Amherst assistant professor who holds a joint appointment in the Elaine Marieb College of Nursing and the College of Engineering’s electrical and computer engineering department, was awarded a projected four-year, $2.3 million grant from the National Institutes of Health’s National Heart, Blood and Lung Institute. Image courtesy of UMass Amherst
News | Heart Failure
Wearing a Vest With Wireless Hardware for Five Minutes a Day May Help People With Heart Failure Stay Out of the Hospital

September 28, 2022 —  A University of Massachusetts Amherst nurse engineer is leading a team of researchers who are ...

Home September 28, 2022
Home
Heart disease prevention pioneer Jeremiah Stamler, MD. Photo courtesy of Legacy.com
Feature | Cardiovascular Business | By Christine Book
Spotlight on Heart Disease Prevention Pioneer, Jeremiah Stamler, MD

World Heart Day takes place each year on September 29. Founded in 2000 by the World Heart Federation, World Heart Day ...

Home September 28, 2022
Home
a late breaking abstract describing dose response data from its positive Phase 2 clinical study of istaroxime in early cardiogenic shock (SEISMiC) will be presented on October 2 at the Heart Failure Society of America Annual Scientific Meeting in Washington, DC.
News | Cardiogenic Shock
Windtree Therapeutics Announces Istaroxime Late Breaker Abstract from its Positive Phase 2 Study in Early Cardiogenic Shock (SEISMiC) to be Presented at Heart Failure Society of America

September 27, 2022 —  Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage ...

Home September 27, 2022
Home
The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).
News | TCT
TCT 2022 Announces Winner of Shark Tank Innovation Award

September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as ...

Home September 20, 2022
Home
FIH study demonstrated feasibility and safety of cardiorenal support among patients undergoing high-risk PCI
News | Heart Failure
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device

September 19, 2022 —  A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has ...

Home September 19, 2022
Home
Study suggests prescribing Philips MCOT (Mobile Cardiac Outpatient Telemetry) solution may support improved patient outcomes and cost savings by monitoring for arrhythmic disturbances and encouraging timely intervention
News | Heart Failure
New Study Validates Ambulatory Monitoring as a Critical Component of Cardiac Care

September 15, 2022 — Today, aortic stenosis (AS) is one of the most common and serious valve disease problems [1]. It ...

Home September 15, 2022
Home
Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System
News | TCT
Valentin Fuster, M.D., Ph.D., Receives Prestigious Award from Cardiovascular Research Foundation

September 15, 2022 — The Cardiovascular Research Foundation (CRF) will honor Valentin Fuster, MD, PhD, Director of Mount ...

Home September 15, 2022
Home
A budget impact analysis published in the Canadian Journal of Cardiology compared the use of surgical (SAVR) versus catheter-based transcatheter aortic valve replacement (TAVR)
News | Heart Failure
TAVR is an Affordable and Effective Strategy for Treating Aortic Stenosis Patients

September 14, 2022 — Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized ...

Home September 14, 2022
Home
Findings reveal AFib patients are fearful of complications from the condition, but not all are treating their AFib quicky after diagnosis
News | Atrial Fibrillation
Biosense Webster AFib Survey Findings Reveal Surprising Patient Behaviors and At-Risk Population Awareness Gaps

September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...

Home September 14, 2022
Home
Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference, Oct. 30-Nov. 3, 2022, have been announced.
News | Cardiovascular Education
Late-breaking Clinical Trial presentations announced for The VEINS and VIVA Conference

September 14, 2022 — Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INte ...

Home September 14, 2022
Home
TherOx Console
News | STEMI
First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients

September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related ...

Home September 13, 2022
Home
DAIC editors outline some highlights of what to expect from this year’s conference.
Feature | TCT | By Melinda Taschetta-Millane
Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference Preview

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) ...

Home September 12, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now